Helus Pharma HELP Growth Metrics (2020-2026)

NASDAQ HELP
$10.36 +0.17 (+1.67%)
At close: Oct 26, 2026 · 4:00 PM EDT
Reported Financials

Helus Pharma Quarterly Growth Metrics

Periods 24 quarters
Latest Jun 2026

Helus Pharma reported asset growth of 64.50% for the quarter ended Jun 2026. These growth metrics cover 24 quarters of results from Sep 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Growth MetricsGrowth Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Growth Ratios
Total Debt (QoQ)
8.98%-1.84%-10.54%-82.90%
Total Debt Growth (1y)
26.97%-83.64%
Share-based Compensation (QoQ)Stock Comp. (QoQ)
11.64%-18.44%-25.36%-35.96%-51.37%-12.34%-50.62%166.78%11.12%591.40%-87.09%208.45%744.41%-90.25%-39.03%-48.38%-49.93%1,087.53%17.40%120.21%
Share-based Compensation Growth (5y)Stock Comp. Growth (5y)
-15.94%-8.56%6.74%10.34%24.41%
Share-based Compensation Growth (3y)Stock Comp. Growth (3y)
-19.11%21.38%31.17%-33.58%-9.22%78.19%-12.21%-17.93%-23.63%-22.88%83.85%145.37%130.17%
Share-based Compensation Growth (1y)Stock Comp. Growth (1y)
634.97%9.42%-17.89%-56.47%-81.04%-79.62%-86.52%-43.84%28.32%912.15%164.69%206.04%2,225.56%-67.19%54.89%-74.08%-98.46%87.14%260.33%1,437.05%
Return on Equity [ROE] (QoQ)ROE (QoQ)
0.00M-291.000.00M-923.00-18.00119.00-253.00919.00-262.00479.000.00M0.00M0.00M349.00-624.000.00M11.0073.0071.000.00M
Return on Equity [ROE] Growth (5y)ROE Growth (5y)
0.00M
Return on Equity [ROE] Growth (3y)ROE Growth (3y)
0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M
Return on Equity [ROE] Growth (1y)ROE Growth (1y)
0.00M0.00M0.00M0.00M767.00523.00883.000.01M0.01M0.00M0.00M0.00M0.00M0.00M0.00M-954.000.00M
Return on Assets [ROA] (QoQ)ROA (QoQ)
0.00M-318.000.00M-740.00-122.0042.00-84.000.00M-32.0067.000.00M915.000.00M416.00-461.00-306.00425.00-742.00-279.000.00M
Return on Assets [ROA] Growth (5y)ROA Growth (5y)
0.00M
Return on Assets [ROA] Growth (3y)ROA Growth (3y)
0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M734.00
Return on Assets [ROA] Growth (1y)ROA Growth (1y)
0.00M0.00M0.00M-903.00894.00983.000.00M0.00M0.00M0.00M0.00M-968.000.00M74.000.00M-902.000.00M
Property, Plant & Equipment (Net) Growth (5y)PP&E (Net) Growth (5y)
-15.07%
Property, Plant & Equipment (Net) Growth (3y)PP&E (Net) Growth (3y)
-23.64%-36.96%-16.32%
Property, Plant & Equipment (Net) Growth (1y)PP&E (Net) Growth (1y)
-10.87%-15.40%-40.95%-49.86%97.89%
Operating Income (QoQ)Op. Inc (QoQ)
Net Income towards Common Stockholders (QoQ)Net Income (QoQ)
-19.35%9.21%0.49%30.46%16.21%3.92%-17.14%-0.64%28.43%-77.25%-23,962,357.23%100.00%-209,634,900.00%82.02%-182.68%-15.49%-37.01%-26.53%-10.14%-1.75%
Net Income towards Common Stockholders Growth (5y)Net Income Growth (5y)
-1,272.78%-1,522.22%-1,309.47%-1,358.90%-1,355.45%
Net Income towards Common Stockholders Growth (3y)Net Income Growth (3y)
-1.06%-7.51%4.84%-5,962.07%35.12%-7,728.63%-4,463.37%-6,362.82%-7,553.39%-8,916.48%-9,782.94%-9,582.04%-9,617.51%
Net Income towards Common Stockholders Growth (1y)Net Income Growth (1y)
-191.12%-3.43%-11.02%25.01%47.35%44.28%34.41%5.09%18.93%-49.56%-30,593,821.03%61.62%-112,415,203.31%-11,403,932.01%-34.53%-123,064,900.00%19.57%-465.96%-120.52%-94.28%
Net Income (QoQ)
-16.83%2.39%-4.64%28.33%25.32%-3.49%-28.24%-6.47%17.92%-151.19%28.89%31.58%-286.82%82.00%-182.40%-15.49%-37.01%-26.53%-10.14%-1.75%
Net Income Growth (5y)
-50.89%-76.01%-37.26%-33.98%-31.91%
Net Income Growth (3y)
-50.87%-64.40%-36.50%-13.32%3.26%-44.18%17.93%-14.26%-33.96%-63.99%-75.35%-66.68%-64.18%
Net Income Growth (1y)
-600.72%-55.88%-31.24%14.48%45.33%42.04%28.97%-5.52%-15.99%-181.52%-56.09%-0.31%-372.71%66.13%-34.53%-127.09%19.57%-465.40%-120.52%-94.28%
Net Cash Flow (QoQ)NCF (QoQ)
319.41%-157.53%16.01%-12.15%-12.64%43.17%21.07%-23.31%219.86%140.53%711.40%-116.04%2.95%3.55%95.53%3,033.98%-240.34%419.30%-133.91%124.20%
Net Cash Flow Growth (5y)NCF Growth (5y)
41.15%-64.75%32.07%-31.88%26.63%
Net Cash Flow Growth (3y)NCF Growth (3y)
-47.59%61.95%-17.55%87.97%-40.61%-47.82%-27.27%52.11%69.54%-52.97%180.69%-105.21%54.61%
Net Cash Flow Growth (1y)NCF Growth (1y)
655.45%-133.13%-140.64%-18.90%-161.04%39.70%43.34%37.70%166.29%380.59%2,984.36%-275.29%-403.87%-221.84%-100.67%222.89%-77.70%688.33%-4,358.43%-63.23%
Income After Tax (QoQ)
Free Cash Flow (QoQ)FCF (QoQ)
-52.27%7.23%22.84%-10.16%-30.52%29.52%-3.68%3.20%-7.37%-122.24%17.12%-26.27%3.89%3.86%24.04%-110.03%-16.14%7.30%-17.12%0.59%
Free Cash Flow Growth (5y)FCF Growth (5y)
-90.88%-80.56%-37.41%-47.10%-38.60%
Free Cash Flow Growth (3y)FCF Growth (3y)
-90.23%-68.92%-43.41%-43.16%-40.41%-20.44%-21.89%-21.25%-50.35%-44.61%-58.45%-65.02%-66.49%
Free Cash Flow Growth (1y)FCF Growth (1y)
-516.67%-57.50%-45.87%-20.06%-2.91%21.81%-5.07%7.67%24.05%-139.48%-91.44%-149.74%-123.54%3.30%11.37%-47.41%-78.14%-71.77%-164.84%-25.35%
EPS (Diluted) (QoQ)
-13.54%12.41%-2.22%33.85%18.51%8.01%-19.33%9.48%28.43%-3,759.24%-27,344,759.80%100.00%-209,634,900.00%82.02%-179.59%-4.26%-26.79%27.97%-34.57%-1.75%
EPS (Diluted) Growth (5y)
-1,575.68%-1,901.17%-1,605.25%-1,701.82%-1,869.00%
EPS (Diluted) Growth (3y)
32.76%25.30%-115.68%-13,799.20%-29.14%-15,743.30%-9,246.19%-12,970.67%-15,111.23%-17,526.22%-16,146.19%-16,810.40%-17,482.60%
EPS (Diluted) Growth (1y)
-21.43%33.66%33.63%32.76%51.74%49.31%40.83%19.03%28.89%-2,883.53%-683,709,684.52%-295.58%-1,158,682,913.01%-5,398,519.38%44.80%-109,881,217.03%33.54%-166.22%-28.13%-25.05%
EPS (Basic) (QoQ)
-13.54%12.41%-2.22%33.85%18.51%8.01%-19.33%9.48%37.10%-24.61%-25,359,179.22%100.00%-209,634,900.00%82.02%-179.59%-4.26%-26.79%27.97%-34.57%-1.75%
EPS (Basic) Growth (5y)
-1,575.68%-1,901.17%-1,605.25%-1,701.82%-1,869.00%
EPS (Basic) Growth (3y)
32.76%28.45%34.22%-4,034.24%-29.14%-15,743.30%-9,246.19%-12,970.67%-15,111.23%-17,526.22%-16,146.19%-16,810.40%-17,482.60%
EPS (Basic) Growth (1y)
-21.43%33.66%33.63%32.76%51.74%49.31%40.83%19.03%37.50%15.34%-17,992,263.78%-295.58%-1,318,450,345.48%-190,251,135.46%-1,997.52%-109,881,217.03%33.54%-166.22%-28.13%-25.05%
EBT (QoQ)
EBIT (QoQ)
Cash from Operations (QoQ)Cash from Ops. (QoQ)
-51.67%7.22%24.51%-13.84%-28.86%29.52%-1.03%0.67%-7.37%-123.71%19.67%-29.42%3.89%2.73%20.86%-100.82%-16.71%7.36%-16.73%0.59%
Cash from Operations Growth (5y)Cash from Ops. Growth (5y)
-91.18%-81.02%-37.45%-48.35%-38.69%
Cash from Operations Growth (3y)Cash from Ops. Growth (3y)
-90.23%-68.92%-43.21%-43.59%-40.15%-20.38%-22.29%-24.23%-50.10%-45.23%-59.08%-66.93%-66.97%
Cash from Operations Growth (1y)Cash from Ops. Growth (1y)
-517.61%-56.10%-47.87%-20.94%-2.75%21.94%-4.46%8.85%24.05%-141.07%-91.68%-149.74%-123.54%2.80%4.25%-48.57%-80.42%-71.82%-153.44%-25.46%
Cash from Investing Activities (QoQ)Cash from Investing (QoQ)
78.25%-88.38%27.46%-70.78%-1,157.68%92.57%-5.74%69.99%-297.71%2,947.30%-102.91%-8.43%-45.09%13.55%-248.14%70.75%-97.29%12.16%15.67%0.93%
Cash from Investing Activities Growth (5y)Cash from Investing Growth (5y)
2.81%-31.88%22.26%0.08%
Cash from Investing Activities Growth (3y)Cash from Investing Growth (3y)
27.39%205.32%48.05%18.65%-53.13%-18.11%-99.23%-10.65%40.33%-35.93%-26.06%-87.70%
Cash from Investing Activities Growth (1y)Cash from Investing Growth (1y)
86.10%-168.40%91.60%49.23%-2,835.02%-15.80%-68.81%70.34%90.62%3,693.26%1.05%-257.52%-30.42%-103.96%-373.48%-27.75%-73.71%-76.50%57.24%-44.80%
Cash & Equivalents (QoQ)Cash & Equiv. (QoQ)
32.68%-15.37%-13.86%-23.31%-33.57%-24.13%-25.95%-42.64%90.33%119.50%423.76%-13.35%-14.61%-16.86%-0.65%132.98%-19.41%5.79%
Cash & Equivalents Growth (5y)Cash & Equiv. Growth (5y)
25.39%30.22%
Cash & Equivalents Growth (3y)Cash & Equiv. Growth (3y)
44.92%44.40%24.68%23.94%29.98%56.40%127.32%133.83%186.75%
Cash & Equivalents Growth (1y)Cash & Equiv. Growth (1y)
-15.29%-25.82%-62.86%-66.70%-71.38%-78.59%-38.66%77.47%1,155.18%1,796.08%750.62%222.19%-38.88%-26.68%105.45%66.66%
Capital Expenditures (QoQ)Capex (QoQ)
58.15%-4.62%991.10%-171.61%403.09%-248.29%69.42%-88.74%12.16%15.67%0.93%
Capital Expenditures Growth (5y)Capex Growth (5y)
-40.87%-30.72%-51.68%
Capital Expenditures Growth (3y)Capex Growth (3y)
-22.32%29.15%-131.63%-89.99%-27.53%-52.37%
Capital Expenditures Growth (1y)Capex Growth (1y)
74.72%-12.51%-179.40%35.07%82.28%-71.68%-297.28%-76.58%57.24%-38.53%
Assets (QoQ)
23.75%-9.70%-9.81%-14.03%-12.70%-11.39%-11.00%46.36%-26.78%129.56%127.55%-6.88%-6.52%-9.03%2.29%16.64%-14.03%60.07%-13.42%3.38%
Assets Growth (5y)
28.04%31.19%
Assets Growth (3y)
45.14%45.96%32.93%33.26%38.97%53.84%53.06%86.41%84.70%64.50%
Assets Growth (1y)
-7.73%-13.36%-38.88%-40.02%-40.81%0.76%-15.49%118.94%459.79%256.18%354.73%80.19%-19.00%1.46%-6.69%64.19%38.97%23.17%

Helus Pharma Growth Metrics API

Pull Helus Pharma's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=HELP&statement=Growth&frequency=Quarter&period=all&api_key=YOUR_API_KEY